M. Niedre

This paper introduces a near-infrared diffuse in vivo flow cytometry (NIR-DiFC) system and demonstrates its effectiveness in detecting circulating tumor cells in vitro and in mice.

This study evaluates the feasibility of detecting fluorescent signals from circulating cells in human blood vessels using diffuse in vivo flow cytometry (DiFC) by analyzing instrument geometry, wavelength, and tissue properties.

This study uses DiFC to show that CTC numbers in mice fluctuate significantly over short timescales, challenging accurate enumeration from small blood samples.

This paper demonstrates the feasibility of using folate receptor-targeted molecular probes to label circulating tumor cells for diffuse in vivo flow cytometry in pre-clinical models.

This study develops a GFP-compatible DiFC method to non-invasively monitor CTC burden and detect CTC clusters in a multiple myeloma xenograft model.

This paper introduces a new technique called Diffuse in vivo Flow Cytometry (DiFC) for detecting rare fluorescently-labeled circulating cells in mice without drawing blood, achieving high accuracy and speed.